Alkermes plc (ALKS) financial statements (2021 and earlier)

Company profile

Business Address CONNAUGHT HOUSE
DUBLIN 4, 00000
State of Incorp.
Fiscal Year End December 31
SIC 2834 - Pharmaceutical Preparations (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in millions)

12/31/2020
12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
12/31/2014
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments635535539434497535631
Cash and cash equivalents273204267191186181224
Short-term investments362331273242311354407
Receivables275257292234191155152
Inventory, net of allowances, customer advances and progress billings1261029093633851
Inventory1261029093633851
Contract with customer, asset1488
Business combination, contingent consideration, asset8      
Deferred tax assets 0001
Other undisclosed current assets53605348392641
Total current assets:1,111962983809791755877
Noncurrent Assets
Operating lease, right-of-use asset13212
Property, plant and equipment350362310285265255266
Long-term investments and receivables257981157122264170
Long-term investments257981157122264170
Intangible assets, net (including goodwill)204244284349411472574
Goodwill93939393939394
Intangible assets, net (excluding goodwill)111151191256318379479
Deferred income tax assets86 
Business combination, contingent consideration, asset253265856355 
Other noncurrent assets17171614271435
Deferred tax assets, net 1119
Other undisclosed noncurrent assets 9786984740(9)
Total noncurrent assets:8398438429889361,1011,044
TOTAL ASSETS:1,9501,8051,8251,7971,7261,8561,921
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities, including:412373334286207169121
Accounts payable46544056463732
Accrued liabilities76937365536350
Employee-related liabilities71      
Other undisclosed accounts payable and accrued liabilities2192262211661076939
Deferred revenue87
Debt311333667
Due to related parties      37
Deferred revenue and credits2223
Contract with customer, liability3
Other undisclosed current liabilities16     (37)
Total current liabilities:438391340291212236131
Noncurrent Liabilities
Long-term debt and lease obligation392280276278281284351
Long-term debt, excluding current maturities272274276278281284351
Operating lease, liability1195
Liabilities, other than long-term debt53493725242145
Deferred revenue and credits67812
Deferred revenue1622
Contract with customer, liability10
Asset retirement obligations      2
Deferred tax liabilities, net   019
Other liabilities37272819171312
Other undisclosed noncurrent liabilities      (2)
Total noncurrent liabilities:444329314303305305394
Total liabilities:883720654594517541524
Stockholders' equity
Stockholders' equity attributable to parent1,0671,0851,1711,2031,2091,3141,397
Common stock2222221
Treasury stock, value(126)(118)(109)(89)(73)(59)(32)
Additional paid in capital2,6862,5862,4672,3392,2322,1151,943
Accumulated other comprehensive loss(1)(2)(3)(4)(3)(4)(3)
Accumulated deficit(1,493)(1,382)(1,185)(1,044)(948)(739)(512)
Total stockholders' equity:1,0671,0851,1711,2031,2091,3141,397
TOTAL LIABILITIES AND EQUITY:1,9501,8051,8251,7971,7261,8561,921

Income statement (P&L) ($ in millions)

12/31/2020
12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
12/31/2014
Revenues1,0391,1711,094903746628619
Revenue, net903746628619
Cost of revenue(178)(180)(176)(155)(132)(142)(216)
Cost of goods and services sold(178)(180)(176)(155)(132)(139)(176)
Gross profit:860991918749614486403
Operating expenses(973)(1,166)(1,017)(897)(822)(710)(490)
Operating loss:(112)(175)(99)(148)(209)(224)(87)
Nonoperating income (expense)16(22)(28)5(6)073
Investment income, nonoperating714954132
Other nonoperating income (expense)141(2)(10)(2)0(2)
Interest and debt expense(9)(14)(2)(12)(2)(13)(13)
Other undisclosed income from continuing operations before equity method investments, income taxes91421221313
Loss from continuing operations before income taxes:(97)(197)(127)(143)(214)(224)(14)
Income tax expense (benefit)(14)0(12)(15)6(3)(16)
Net loss available to common stockholders, diluted:(111)(197)(139)(158)(208)(227)(30)

Comprehensive Income ($ in millions)

12/31/2020
12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
12/31/2014
Net loss:(111)(197)(139)(158)(208)(227)(30)
Other comprehensive loss     (0)(8)
Comprehensive loss:(111)(197)(139)(158)(208)(227)(38)
Other undisclosed comprehensive income (loss), net of tax, attributable to parent011(1)1(0)(6)
Comprehensive loss, net of tax, attributable to parent:(110)(195)(139)(158)(208)(228)(44)

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: